Business Description
Aevi Genomic Medicine Inc
NAICS : 325414
SIC : 2836
ISIN : US58436Q2030
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 29.1 | |||||
3-Year EPS without NRI Growth Rate | 29.9 | |||||
3-Year FCF Growth Rate | 22 | |||||
3-Year Book Growth Rate | -57 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.65 | |||||
Quick Ratio | 0.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -429.8 | |||||
ROA % | -204.16 | |||||
ROIC % | -69143.88 | |||||
ROC (Joel Greenblatt) % | -130369.86 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.55 | |||||
EV-to-EBITDA | -0.55 | |||||
Earnings Yield (Greenblatt) % | -181.82 | |||||
FCF Yield % | -146.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aevi Genomic Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | |||
EPS (TTM) (£) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (£) | 0 | ||
20-Day SMA (£) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (£) | 3.85 - 9 | ||
Shares Outstanding (Mil) | 18.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aevi Genomic Medicine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aevi Genomic Medicine Inc Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Aevi Genomic Medicine Inc Frequently Asked Questions
What is Aevi Genomic Medicine Inc(LSE:MEDU)'s stock price today?
When is next earnings date of Aevi Genomic Medicine Inc(LSE:MEDU)?
Does Aevi Genomic Medicine Inc(LSE:MEDU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |